ID   GFP_AEQVI               Reviewed;         238 AA.
AC   P42212; Q17104; Q27903; Q93125;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   26-FEB-2020, entry version 165.
DE   RecName: Full=Green fluorescent protein;
GN   Name=GFP;
OS   Aequorea victoria (Jellyfish).
OC   Eukaryota; Metazoa; Cnidaria; Hydrozoa; Hydroidolina; Leptothecata;
OC   Aequoreidae; Aequorea.
OX   NCBI_TaxID=6100;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANTS TYR-100;
RP   SER-108; MET-141 AND ILE-219.
RX   PubMed=1347277; DOI=10.1016/0378-1119(92)90691-h;
RA   Prasher D.C., Eckenrode V.K., Ward W.W., Prendergast F.G., Cormier M.J.;
RT   "Primary structure of the Aequorea victoria green-fluorescent protein.";
RL   Gene 111:229-233(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8137953; DOI=10.1016/0014-5793(94)80472-9;
RA   Inouye S., Tsuji F.I.;
RT   "Aequorea green fluorescent protein. Expression of the gene and
RT   fluorescence characteristics of the recombinant protein.";
RL   FEBS Lett. 341:277-280(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   BIOTECHNOLOGY.
RX   PubMed=9154981; DOI=10.1023/a:1005740823703;
RA   Rouwendal G.J.A., Mendes O., Wolbert E.J.H., de Boer A.D.;
RT   "Enhanced expression in tobacco of the gene encoding green fluorescent
RT   protein by modification of its codon usage.";
RL   Plant Mol. Biol. 33:989-999(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], BIOTECHNOLOGY, AND MUTAGENESIS OF
RP   PHE-64; SER-65; VAL-68 AND SER-72.
RX   PubMed=8707053; DOI=10.1016/0378-1119(95)00685-0;
RA   Cormack B.P., Valdivia R.H., Falkow S.;
RT   "FACS-optimized mutants of the green fluorescent protein (GFP).";
RL   Gene 173:33-38(1996).
RN   [5]
RP   CHROMOPHORE, AND DEHYDROGENATION AT TYR-66.
RX   PubMed=8448132; DOI=10.1021/bi00056a003;
RA   Cody C.W., Prasher D.C., Westler W.M., Prendergast F.G., Ward W.W.;
RT   "Chemical structure of the hexapeptide chromophore of the Aequorea green-
RT   fluorescent protein.";
RL   Biochemistry 32:1212-1218(1993).
RN   [6]
RP   MUTAGENESIS OF TYR-66; ILE-167; SER-202 AND THR-203.
RX   PubMed=7809066; DOI=10.1073/pnas.91.26.12501;
RA   Heim R., Prasher D.C., Tsien R.Y.;
RT   "Wavelength mutations and posttranslational autoxidation of green
RT   fluorescent protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:12501-12504(1994).
RN   [7]
RP   MUTAGENESIS OF PHE-64; SER-65 AND GLN-69.
RX   PubMed=9634755; DOI=10.1038/nbt0295-151;
RA   Delagrave S., Hawtin R.E., Silva C.M., Yang M.M., Youvan D.C.;
RT   "Red-shifted excitation mutants of the green fluorescent protein.";
RL   Biotechnology (N.Y.) 13:151-154(1995).
RN   [8]
RP   MUTAGENESIS OF THR-203 AND GLU-222.
RX   PubMed=7796912; DOI=10.1016/0014-5793(95)00557-p;
RA   Ehrig T., O'Kane D.J., Prendergast F.G.;
RT   "Green-fluorescent protein mutants with altered fluorescence excitation
RT   spectra.";
RL   FEBS Lett. 367:163-166(1995).
RN   [9]
RP   MUTAGENESIS OF TYR-66, AND BIOTECHNOLOGY.
RX   PubMed=8578587; DOI=10.1016/s0968-0004(00)89099-4;
RA   Cubitt A.B., Heim R., Adams S.R., Boyd A.E., Gross L.A., Tsien R.Y.;
RT   "Understanding, improving and using green fluorescent proteins.";
RL   Trends Biochem. Sci. 20:448-455(1995).
RN   [10]
RP   MUTAGENESIS OF VAL-163 AND SER-175.
RX   PubMed=8994830; DOI=10.1016/s0960-9822(02)70789-6;
RA   Siemering K.R., Golbik R., Sever R., Haseloff J.;
RT   "Mutations that suppress the thermosensitivity of green fluorescent
RT   protein.";
RL   Curr. Biol. 6:1653-1663(1996).
RN   [11]
RP   MUTAGENESIS OF PHE-99; MET-153 AND VAL-163.
RX   PubMed=9630892; DOI=10.1038/nbt0396-315;
RA   Crameri A., Whitehorn E.A., Tate E., Stemmer W.P.;
RT   "Improved green fluorescent protein by molecular evolution using DNA
RT   shuffling.";
RL   Nat. Biotechnol. 14:315-319(1996).
RN   [12]
RP   MUTAGENESIS OF PHE-99; MET-153 AND VAL-163.
RX   PubMed=9631088; DOI=10.1038/nbt1096-1252;
RA   Yokoe H., Meyer T.;
RT   "Spatial dynamics of GFP-tagged proteins investigated by local fluorescence
RT   enhancement.";
RL   Nat. Biotechnol. 14:1252-1256(1996).
RN   [13]
RP   MUTAGENESIS OF SER-147.
RX   PubMed=9125154; DOI=10.1006/bbrc.1997.6235;
RA   Kimata Y., Iwaki M., Lim C.R., Kohno K.;
RT   "A novel mutation which enhances the fluorescence of green fluorescent
RT   protein at high temperatures.";
RL   Biochem. Biophys. Res. Commun. 232:69-73(1997).
RN   [14]
RP   MUTAGENESIS OF PHE-64; SER-65; TYR-66; PHE-99; MET-153 AND VAL-163.
RX   PubMed=9370472; DOI=10.1016/s0006-3495(97)78307-3;
RA   Patterson G.H., Knobel S.M., Sharif W.D., Kain S.R., Piston D.W.;
RT   "Use of the green fluorescent protein and its mutants in quantitative
RT   fluorescence microscopy.";
RL   Biophys. J. 73:2782-2790(1997).
RN   [15]
RP   REVIEW ON MUTAGENESIS, AND BIOTECHNOLOGY.
RX   PubMed=9759496; DOI=10.1146/annurev.biochem.67.1.509;
RA   Tsien R.Y.;
RT   "The green fluorescent protein.";
RL   Annu. Rev. Biochem. 67:509-544(1998).
RN   [16]
RP   MUTAGENESIS OF SER-65; VAL-68; SER-72; ASN-146; MET-153; VAL-163 AND
RP   THR-203.
RX   PubMed=11299042; DOI=10.1186/1471-213x-1-4;
RA   Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M.,
RA   Costantini F.;
RT   "Cre reporter strains produced by targeted insertion of EYFP and ECFP into
RT   the ROSA26 locus.";
RL   BMC Dev. Biol. 1:4-4(2001).
RN   [17]
RP   MUTAGENESIS OF PHE-64 AND SER-65.
RX   PubMed=11776264;
RA   Baumstark-Khan C., Hellweg C.E., Palm M., Horneck G.;
RT   "Enhanced green fluorescent protein (EGFP) for space radiation research
RT   using mammalian cells in the International Space Station.";
RL   Phys. Med. 17:210-214(2001).
RN   [18]
RP   MUTAGENESIS OF SER-72; TYR-145 AND THR-203.
RX   PubMed=12769828; DOI=10.1186/1472-6750-3-5;
RA   Zapata-Hommer O., Griesbeck O.;
RT   "Efficiently folding and circularly permuted variants of the Sapphire
RT   mutant of GFP.";
RL   BMC Biotechnol. 3:5-5(2003).
RN   [19]
RP   MUTAGENESIS OF PHE-64; SER-65; TYR-66; ASN-146; MET-153 AND VAL-163.
RX   PubMed=15065907; DOI=10.1117/1.1646416;
RA   Wang Z., Shah J.V., Chen Z., Sun C.H., Berns M.W.;
RT   "Fluorescence correlation spectroscopy investigation of a GFP mutant-
RT   enhanced cyan fluorescent protein and its tubulin fusion in living cells
RT   with two-photon excitation.";
RL   J. Biomed. Opt. 9:395-403(2004).
RN   [20]
RP   MUTAGENESIS OF PHE-64; SER-65; TYR-66; SER-72; TYR-145; ASN-146; HIS-148;
RP   MET-153 AND VAL-163.
RX   PubMed=14990965; DOI=10.1038/nbt945;
RA   Rizzo M.A., Springer G.H., Granada B., Piston D.W.;
RT   "An improved cyan fluorescent protein variant useful for FRET.";
RL   Nat. Biotechnol. 22:445-449(2004).
RN   [21]
RP   MUTAGENESIS OF SER-30; PHE-46; GLN-69; ASP-103; TYR-145; VAL-176; VAL-193
RP   AND ASN-198.
RX   PubMed=16201762; DOI=10.1021/bi050550f;
RA   Scruggs A.W., Flores C.L., Wachter R., Woodbury N.W.;
RT   "Development and characterization of green fluorescent protein mutants with
RT   altered lifetimes.";
RL   Biochemistry 44:13377-13384(2005).
RN   [22]
RP   MUTAGENESIS OF ALA-206.
RX   PubMed=16739159; DOI=10.1002/cphc.200600057;
RA   Grailhe R., Merola F., Ridard J., Couvignou S., Le Poupon C.,
RA   Changeux J.P., Laguitton-Pasquier H.;
RT   "Monitoring protein interactions in the living cell through the
RT   fluorescence decays of the cyan fluorescent protein.";
RL   ChemPhysChem 7:1442-1454(2006).
RN   [23]
RP   MUTAGENESIS OF PHE-64; SER-65; SER-72; ASN-149; MET-153 AND ILE-167.
RX   PubMed=17658219; DOI=10.1016/j.bbagen.2007.06.005;
RA   Teerawanichpan P., Hoffman T., Ashe P., Datla R., Selvaraj G.;
RT   "Investigations of combinations of mutations in the jellyfish green
RT   fluorescent protein (GFP) that afford brighter fluorescence, and use of a
RT   version (VisGreen) in plant, bacterial, and animal cells.";
RL   Biochim. Biophys. Acta 1770:1360-1368(2007).
RN   [24]
RP   BIOTECHNOLOGY.
RX   PubMed=17685514; DOI=10.1021/ja0715905;
RA   Wong F.H., Banks D.S., Abu-Arish A., Fradin C.;
RT   "A molecular thermometer based on fluorescent protein blinking.";
RL   J. Am. Chem. Soc. 129:10302-10303(2007).
RN   [25]
RP   MUTAGENESIS OF PHE-46; PHE-64; VAL-68; LYS-162; VAL-163; ILE-167 AND
RP   ILE-171.
RX   PubMed=18366185; DOI=10.1021/bi702130s;
RA   Mishin A.S., Subach F.V., Yampolsky I.V., King W., Lukyanov K.A.,
RA   Verkhusha V.V.;
RT   "The first mutant of the Aequorea victoria green fluorescent protein that
RT   forms a red chromophore.";
RL   Biochemistry 47:4666-4673(2008).
RN   [26]
RP   MUTAGENESIS OF SER-30; TYR-39; TYR-66; SER-72; GLN-80; ASN-105; ILE-128;
RP   TYR-145; VAL-150; ASP-155; ILE-171; ASN-198; ALA-206 AND VAL-224.
RX   PubMed=22891786; DOI=10.1021/jp306257t;
RA   Park J.W., Rhee Y.M.;
RT   "Interpolated mechanics-molecular mechanics study of internal rotation
RT   dynamics of the chromophore unit in blue fluorescent protein and its
RT   variants.";
RL   J. Phys. Chem. B 116:11137-11147(2012).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   PubMed=9631087; DOI=10.1038/nbt1096-1246;
RA   Yang F., Moss L.G., Phillips G.N. Jr.;
RT   "The molecular structure of green fluorescent protein.";
RL   Nat. Biotechnol. 14:1246-1251(1996).
RN   [28] {ECO:0000244|PDB:1EMA}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS), AND MUTAGENESIS OF SER-65 AND
RP   THR-203.
RX   PubMed=8703075; DOI=10.1126/science.273.5280.1392;
RA   Ormo M., Cubitt A.B., Kallio K., Gross L.A., Tsien R.Y., Remington S.J.;
RT   "Crystal structure of the Aequorea victoria green fluorescent protein.";
RL   Science 273:1392-1395(1996).
RN   [29] {ECO:0000244|PDB:1EMC, ECO:0000244|PDB:1EME, ECO:0000244|PDB:1EMF, ECO:0000244|PDB:1EMK, ECO:0000244|PDB:1EML, ECO:0000244|PDB:1EMM, ECO:0000244|PDB:2EMD, ECO:0000244|PDB:2EMN, ECO:0000244|PDB:2EMO}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS), MUTAGENESIS OF PHE-64; TYR-66;
RP   SER-72; ASN-149; MET-153 AND ILE-167, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   BIOTECHNOLOGY.
RX   PubMed=9145105; DOI=10.1038/nsb0597-361;
RA   Palm G.J., Zdanov A., Gaitanaris G.A., Stauber R., Pavlakis G.N.,
RA   Wlodawer A.;
RT   "The structural basis for spectral variations in green fluorescent
RT   protein.";
RL   Nat. Struct. Biol. 4:361-365(1997).
RN   [30] {ECO:0000244|PDB:1YFP, ECO:0000244|PDB:2YFP}
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF YELLOW EMISSION MUTANT
RP   TYR-203/GLY-65/LEU-68/ALA-72, MUTAGENESIS OF SER-65; VAL-68; SER-72 AND
RP   THR-203, BIOPHYSICOCHEMICAL PROPERTIES, BIOTECHNOLOGY, AND SUBUNIT.
RX   PubMed=9782051; DOI=10.1016/s0969-2126(98)00127-0;
RA   Wachter R.M., Elsliger M.-A., Kallio K., Hanson G.T., Remington S.J.;
RT   "Structural basis of spectral shifts in the yellow-emission variants of
RT   green fluorescent protein.";
RL   Structure 6:1267-1277(1998).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10220315; DOI=10.1021/bi9902182;
RA   Elsliger M.-A., Wachter R.M., Hanson G.T., Kallio K., Remington S.J.;
RT   "Structural and spectral response of green fluorescent protein variants to
RT   changes in pH.";
RL   Biochemistry 38:5296-5301(1999).
RN   [32] {ECO:0000244|PDB:1HUY}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2-238 OF MUTANT CITRININE, AND
RP   MUTAGENESIS OF VAL-68; GLN-69; SER-72 AND THR-203.
RX   PubMed=11387331; DOI=10.1074/jbc.m102815200;
RA   Griesbeck O., Baird G.S., Campbell R.E., Zacharias D.A., Tsien R.Y.;
RT   "Reducing the environmental sensitivity of yellow fluorescent protein.
RT   Mechanism and applications.";
RL   J. Biol. Chem. 276:29188-29194(2001).
RN   [33] {ECO:0000244|PDB:1MYW}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2-238 OF VENUS, AND MUTAGENESIS
RP   OF PHE-46; PHE-64; SER-65; VAL-68; SER-72; MET-153; VAL-163; SER-175 AND
RP   THR-203.
RX   PubMed=12370172; DOI=10.1074/jbc.m209524200;
RA   Rekas A., Alattia J.R., Nagai T., Miyawaki A., Ikura M.;
RT   "Crystal structure of venus, a yellow fluorescent protein with improved
RT   maturation and reduced environmental sensitivity.";
RL   J. Biol. Chem. 277:50573-50578(2002).
RN   [34] {ECO:0000244|PDB:2Q57}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS), MUTAGENESIS OF 65-SER-TYR-66,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND BIOTECHNOLOGY.
RX   PubMed=17685554; DOI=10.1021/bi602664c;
RA   Malo G.D., Pouwels L.J., Wang M., Weichsel A., Montfort W.R., Rizzo M.A.,
RA   Piston D.W., Wachter R.M.;
RT   "X-ray structure of Cerulean GFP: a tryptophan-based chromophore useful for
RT   fluorescence lifetime imaging.";
RL   Biochemistry 46:9865-9873(2007).
CC   -!- FUNCTION: Energy-transfer acceptor. Its role is to transduce the blue
CC       chemiluminescence of the protein aequorin into green fluorescent light
CC       by energy transfer. Fluoresces in vivo upon receiving energy from the
CC       Ca(2+)-activated photoprotein aequorin.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Absorption:
CC         Abs(max)=395 nm;
CC         Note=Exhibits a smaller absorbance peak at 470 nm. The fluorescence
CC         emission spectrum peaks at 507-510 nm with a shoulder at 545 nm
CC         (PubMed:8137953, PubMed:9154981). The exact value of the emission
CC         maximum depends on the environment of the chromophore
CC         (PubMed:10220315). As a consequence, mutant versions have been
CC         designed that have substantially shifted emission spectra, including
CC         yellow-emission variants (YFP), blue and cerulean fluorescing
CC         proteins (PubMed:9145105, PubMed:9782051, PubMed:17685554).
CC         {ECO:0000269|PubMed:10220315, ECO:0000269|PubMed:17685554,
CC         ECO:0000269|PubMed:8137953, ECO:0000269|PubMed:9145105,
CC         ECO:0000269|PubMed:9154981, ECO:0000269|PubMed:9782051};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:9782051}.
CC   -!- TISSUE SPECIFICITY: Photocytes.
CC   -!- PTM: Contains a chromophore consisting of modified amino acid residues.
CC       The chromophore is formed by autocatalytic backbone condensation
CC       between Ser-65 and Gly-67, and oxidation of Tyr-66 to
CC       didehydrotyrosine. Maturation of the chromophore requires nothing other
CC       than molecular oxygen. {ECO:0000269|PubMed:8448132}.
CC   -!- BIOTECHNOLOGY: Green fluorescent protein has been engineered to produce
CC       a vast number of variously colored mutants, fusion proteins, and
CC       biosensors. Green fluorescent protein can be mutated to emit at
CC       different wavelengths such as blue for BFP (when Tyr-66 is replaced by
CC       His), cyan for CFP (when Tyr-66 is replaced by Trp), and yellow for YFP
CC       (when THR-203 is replaced by Tyr). Further generation of mutants led to
CC       more stable proteins (at 37 degrees Celsius for example) with brighter
CC       fluorescence and longer fluorescence lifetimes. Fluorescent proteins
CC       and their mutated allelic forms have become a useful and ubiquitous
CC       tool for making chimeric proteins, where they function as a fluorescent
CC       protein tag. Typically they tolerate N- and C-terminal fusion to a
CC       broad variety of proteins. They have been expressed in most known cell
CC       types and are used as a noninvasive fluorescent marker in living cells
CC       and organisms. They enable a wide range of applications where they have
CC       functioned as a cell lineage tracer, reporter of gene expression, or as
CC       a measure of protein-protein interactions (PubMed:17685514,
CC       PubMed:17685554, PubMed:8578587, PubMed:8707053, PubMed:9145105,
CC       PubMed:9154981, PubMed:9759496, PubMed:9782051). Can also be used as a
CC       molecular thermometer, allowing accurate temperature measurements in
CC       fluids. The measurement process relies on the detection of the blinking
CC       of GFP using fluorescence correlation spectroscopy (PubMed:17685514).
CC       {ECO:0000269|PubMed:17685514, ECO:0000269|PubMed:17685554,
CC       ECO:0000269|PubMed:8578587, ECO:0000269|PubMed:8707053,
CC       ECO:0000269|PubMed:9145105, ECO:0000269|PubMed:9154981,
CC       ECO:0000269|PubMed:9759496, ECO:0000269|PubMed:9782051}.
CC   -!- SIMILARITY: Belongs to the GFP family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The greenest of us all
CC       - Issue 11 of June 2001;
CC       URL="https://web.expasy.org/spotlight/back_issues/011";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Paint my thoughts - Issue
CC       108 of August 2009;
CC       URL="https://web.expasy.org/spotlight/back_issues/108";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Green fluorescent protein entry;
CC       URL="https://en.wikipedia.org/wiki/Green_fluorescent_protein";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Paint my thoughts - Issue
CC       108 of November 2007;
CC       URL="https://web.expasy.org/spotlight/back_issues/108/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M62654; AAA27722.1; -; mRNA.
DR   EMBL; M62653; AAA27721.1; -; mRNA.
DR   EMBL; L29345; AAA58246.1; -; mRNA.
DR   EMBL; X96418; CAA65278.1; -; mRNA.
DR   EMBL; U73901; AAB18957.1; -; Genomic_DNA.
DR   PIR; JS0692; JQ1514.
DR   PDB; 1B9C; X-ray; 2.40 A; A/B/C/D=1-238.
DR   PDB; 1BFP; X-ray; 2.10 A; A=1-238.
DR   PDB; 1C4F; X-ray; 2.25 A; A=1-238.
DR   PDB; 1CV7; X-ray; 2.50 A; A=1-228.
DR   PDB; 1EMA; X-ray; 1.90 A; A=1-238.
DR   PDB; 1EMB; X-ray; 2.13 A; A=1-238.
DR   PDB; 1EMC; X-ray; 2.30 A; A/B/C/D=2-237.
DR   PDB; 1EME; X-ray; 2.50 A; A=2-237.
DR   PDB; 1EMF; X-ray; 2.40 A; A=2-238.
DR   PDB; 1EMG; X-ray; 2.00 A; A=1-229.
DR   PDB; 1EMK; X-ray; 2.10 A; A=2-237.
DR   PDB; 1EML; X-ray; 2.30 A; A=2-237.
DR   PDB; 1EMM; X-ray; 2.30 A; A=2-238.
DR   PDB; 1F09; X-ray; 2.14 A; A=1-238.
DR   PDB; 1F0B; X-ray; 2.10 A; A=1-238.
DR   PDB; 1GFL; X-ray; 1.90 A; A/B=2-238.
DR   PDB; 1H6R; X-ray; 1.50 A; A/B/C=1-238.
DR   PDB; 1HCJ; X-ray; 1.80 A; A/B/C/D=1-238.
DR   PDB; 1HUY; X-ray; 2.20 A; A=2-238.
DR   PDB; 1JBY; X-ray; 1.80 A; A=1-238.
DR   PDB; 1JBZ; X-ray; 1.50 A; A=1-238.
DR   PDB; 1JC0; X-ray; 2.00 A; A/B/C=1-238.
DR   PDB; 1JC1; X-ray; 1.90 A; A/B/C=1-238.
DR   PDB; 1KP5; X-ray; 2.60 A; A/B=1-238.
DR   PDB; 1KYP; X-ray; 1.35 A; A=2-238.
DR   PDB; 1KYR; X-ray; 1.50 A; A=2-238.
DR   PDB; 1KYS; X-ray; 1.44 A; A=2-238.
DR   PDB; 1MYW; X-ray; 2.20 A; A=2-238.
DR   PDB; 1Q4A; X-ray; 1.45 A; A=1-238.
DR   PDB; 1Q4B; X-ray; 1.48 A; A=1-238.
DR   PDB; 1Q4C; X-ray; 1.55 A; A=1-238.
DR   PDB; 1Q4D; X-ray; 1.58 A; A=1-238.
DR   PDB; 1Q4E; X-ray; 1.38 A; A=1-238.
DR   PDB; 1Q73; X-ray; 1.60 A; A=1-238.
DR   PDB; 1QXT; X-ray; 2.00 A; A=2-229.
DR   PDB; 1QY3; X-ray; 2.00 A; A=1-229.
DR   PDB; 1QYF; X-ray; 1.50 A; A=1-227.
DR   PDB; 1QYO; X-ray; 1.80 A; A=1-238.
DR   PDB; 1QYQ; X-ray; 1.80 A; A=2-238.
DR   PDB; 1RM9; X-ray; 2.90 A; A=2-236.
DR   PDB; 1RMM; X-ray; 1.90 A; A=2-227.
DR   PDB; 1RMO; X-ray; 1.80 A; A=2-236.
DR   PDB; 1RMP; X-ray; 3.00 A; A=2-229.
DR   PDB; 1RRX; X-ray; 2.10 A; A=2-227.
DR   PDB; 1S6Z; X-ray; 1.50 A; A=1-238.
DR   PDB; 1W7S; X-ray; 1.85 A; A/B/C/D=1-238.
DR   PDB; 1W7T; X-ray; 1.85 A; A/B/C/D=1-238.
DR   PDB; 1W7U; X-ray; 1.85 A; A/B/C/D=1-238.
DR   PDB; 1YFP; X-ray; 2.50 A; A/B=3-229.
DR   PDB; 1YHG; X-ray; 2.50 A; A/B=2-238.
DR   PDB; 1YHH; X-ray; 1.50 A; A=2-238.
DR   PDB; 1YHI; X-ray; 1.90 A; A=2-238.
DR   PDB; 1YJ2; X-ray; 1.50 A; A=2-238.
DR   PDB; 1YJF; X-ray; 1.35 A; A=2-238.
DR   PDB; 1Z1P; X-ray; 2.00 A; A=1-238.
DR   PDB; 1Z1Q; X-ray; 1.50 A; A=1-238.
DR   PDB; 2AH8; X-ray; 2.24 A; A/B=1-238.
DR   PDB; 2AHA; X-ray; 1.98 A; A/B=1-238.
DR   PDB; 2AWJ; X-ray; 1.60 A; A=2-229.
DR   PDB; 2AWK; X-ray; 1.15 A; A=1-229.
DR   PDB; 2AWL; X-ray; 1.85 A; A=1-229.
DR   PDB; 2AWM; X-ray; 1.70 A; A=1-229.
DR   PDB; 2B3P; X-ray; 1.40 A; A=1-238.
DR   PDB; 2B3Q; X-ray; 2.30 A; A/B/C/D=1-238.
DR   PDB; 2DUE; X-ray; 1.24 A; A=1-238.
DR   PDB; 2DUF; X-ray; 1.50 A; A=1-238.
DR   PDB; 2DUG; X-ray; 1.40 A; A=1-238.
DR   PDB; 2DUH; X-ray; 1.20 A; A=1-238.
DR   PDB; 2DUI; X-ray; 1.36 A; A=1-238.
DR   PDB; 2EMD; X-ray; 2.00 A; A=1-238.
DR   PDB; 2EMN; X-ray; 2.30 A; A=1-238.
DR   PDB; 2EMO; X-ray; 2.60 A; A=1-238.
DR   PDB; 2FWQ; X-ray; 1.40 A; A=2-238.
DR   PDB; 2FZU; X-ray; 1.25 A; A=2-238.
DR   PDB; 2G16; X-ray; 2.00 A; A=2-64, B=67-238.
DR   PDB; 2G2S; X-ray; 1.20 A; A=2-63, B=66-238.
DR   PDB; 2G3D; X-ray; 1.35 A; A=2-63, B=66-238.
DR   PDB; 2G5Z; X-ray; 1.80 A; A=2-65, B=66-238.
DR   PDB; 2G6E; X-ray; 1.30 A; A=2-238.
DR   PDB; 2H6V; X-ray; 1.47 A; A=2-238.
DR   PDB; 2H9W; X-ray; 1.82 A; A=2-237.
DR   PDB; 2HCG; X-ray; 1.35 A; A=2-238.
DR   PDB; 2HFC; X-ray; 1.20 A; A=2-238.
DR   PDB; 2HGD; X-ray; 1.60 A; A=2-238.
DR   PDB; 2HGY; X-ray; 2.05 A; A=2-238.
DR   PDB; 2HJO; X-ray; 1.25 A; A=1-238.
DR   PDB; 2HQZ; X-ray; 1.20 A; A=1-238.
DR   PDB; 2HRS; X-ray; 1.40 A; A=1-238.
DR   PDB; 2JAD; X-ray; 2.70 A; A=1-238.
DR   PDB; 2O24; X-ray; 1.45 A; A=2-238.
DR   PDB; 2O29; X-ray; 1.80 A; A=2-238.
DR   PDB; 2O2B; X-ray; 1.94 A; A=2-238.
DR   PDB; 2OKW; X-ray; 1.90 A; A/B/C/D/E/F=1-238.
DR   PDB; 2OKY; X-ray; 2.40 A; A/B=1-238.
DR   PDB; 2Q57; X-ray; 2.00 A; A=1-238.
DR   PDB; 2Q6P; X-ray; 2.10 A; A=1-238.
DR   PDB; 2QRF; X-ray; 1.50 A; A=1-230.
DR   PDB; 2QT2; X-ray; 1.31 A; A=1-238.
DR   PDB; 2QU1; X-ray; 1.70 A; A=1-238.
DR   PDB; 2QZ0; X-ray; 1.20 A; A=2-229.
DR   PDB; 2WSN; X-ray; 1.37 A; A=2-238.
DR   PDB; 2WSO; X-ray; 1.15 A; A=2-238.
DR   PDB; 2WUR; X-ray; 0.90 A; A=1-237.
DR   PDB; 2Y0G; X-ray; 1.50 A; A=2-238.
DR   PDB; 2YDZ; X-ray; 1.59 A; A=2-238.
DR   PDB; 2YE0; X-ray; 1.47 A; A=2-238.
DR   PDB; 2YE1; X-ray; 1.63 A; A=2-238.
DR   PDB; 2YFP; X-ray; 2.60 A; A=1-238.
DR   PDB; 3AI4; X-ray; 1.60 A; A=1-230.
DR   PDB; 3CB9; X-ray; 1.31 A; A=2-238.
DR   PDB; 3CBE; X-ray; 1.49 A; A=2-238.
DR   PDB; 3CD1; X-ray; 1.31 A; A=2-238.
DR   PDB; 3CD9; X-ray; 1.50 A; A=2-238.
DR   PDB; 3DPW; X-ray; 1.59 A; A=2-238.
DR   PDB; 3DPX; X-ray; 1.50 A; A=2-238.
DR   PDB; 3DPZ; X-ray; 1.70 A; A=2-238.
DR   PDB; 3DQ1; X-ray; 1.70 A; A=2-238.
DR   PDB; 3DQ2; X-ray; 1.60 A; A=2-238.
DR   PDB; 3DQ3; X-ray; 1.70 A; A=2-238.
DR   PDB; 3DQ4; X-ray; 1.47 A; A=2-238.
DR   PDB; 3DQ5; X-ray; 1.50 A; A=2-238.
DR   PDB; 3DQ6; X-ray; 1.60 A; A=2-238.
DR   PDB; 3DQ7; X-ray; 1.23 A; A=2-238.
DR   PDB; 3DQ8; X-ray; 1.51 A; A=2-238.
DR   PDB; 3DQ9; X-ray; 1.40 A; A=2-238.
DR   PDB; 3DQA; X-ray; 1.44 A; A=2-238.
DR   PDB; 3DQC; X-ray; 1.49 A; A=2-238.
DR   PDB; 3DQD; X-ray; 1.40 A; A=2-238.
DR   PDB; 3DQE; X-ray; 1.43 A; A=2-238.
DR   PDB; 3DQF; X-ray; 1.46 A; A=2-238.
DR   PDB; 3DQH; X-ray; 1.45 A; A=2-238.
DR   PDB; 3DQI; X-ray; 1.42 A; A=2-238.
DR   PDB; 3DQJ; X-ray; 1.51 A; A=2-238.
DR   PDB; 3DQK; X-ray; 1.40 A; A=2-238.
DR   PDB; 3DQL; X-ray; 1.47 A; A=2-238.
DR   PDB; 3DQM; X-ray; 1.44 A; A=2-238.
DR   PDB; 3DQN; X-ray; 1.44 A; A=2-238.
DR   PDB; 3DQO; X-ray; 1.50 A; A=2-238.
DR   PDB; 3DQU; X-ray; 1.42 A; A=2-238.
DR   PDB; 3ED8; X-ray; 2.70 A; A/B/C/D/E=2-238.
DR   PDB; 3EK4; X-ray; 2.65 A; A=2-238.
DR   PDB; 3EK7; X-ray; 1.85 A; A=2-238.
DR   PDB; 3EK8; X-ray; 2.80 A; A=2-238.
DR   PDB; 3EKH; X-ray; 2.00 A; A=2-238.
DR   PDB; 3EKJ; X-ray; 2.80 A; A=2-238.
DR   PDB; 3EVP; X-ray; 1.45 A; A=2-144.
DR   PDB; 3EVR; X-ray; 2.00 A; A=2-144.
DR   PDB; 3EVU; X-ray; 1.75 A; A=2-144.
DR   PDB; 3EVV; X-ray; 2.60 A; A=2-238.
DR   PDB; 3G9A; X-ray; 1.61 A; A=1-238.
DR   PDB; 3GEX; X-ray; 1.60 A; A=1-238.
DR   PDB; 3GJ1; X-ray; 1.80 A; A/B/C/D=1-230.
DR   PDB; 3GJ2; X-ray; 1.90 A; A/B/C/D=1-230.
DR   PDB; 3I19; X-ray; 1.36 A; A=1-238.
DR   PDB; 3K1K; X-ray; 2.15 A; A/B=1-238.
DR   PDB; 3LA1; X-ray; 1.29 A; A=1-238.
DR   PDB; 3O77; X-ray; 2.35 A; A=2-238.
DR   PDB; 3O78; X-ray; 2.60 A; A/B=2-237.
DR   PDB; 3OGO; X-ray; 2.80 A; A/B/C/D=1-238.
DR   PDB; 3OSQ; X-ray; 1.90 A; A=2-238.
DR   PDB; 3OSR; X-ray; 2.00 A; A/B=2-238.
DR   PDB; 3P28; X-ray; 1.80 A; A=3-229.
DR   PDB; 3SG2; X-ray; 2.00 A; A=2-238.
DR   PDB; 3SG3; X-ray; 2.10 A; A=2-238.
DR   PDB; 3SG4; X-ray; 2.40 A; A=2-238.
DR   PDB; 3SG5; X-ray; 1.90 A; A=2-238.
DR   PDB; 3SG6; X-ray; 1.70 A; A=2-238.
DR   PDB; 3SG7; X-ray; 1.90 A; A=2-238.
DR   PDB; 3SRY; X-ray; 1.16 A; A=2-238.
DR   PDB; 3SS0; X-ray; 1.49 A; A=2-238.
DR   PDB; 3SSH; X-ray; 1.28 A; A=2-238.
DR   PDB; 3SSK; X-ray; 1.36 A; A=2-238.
DR   PDB; 3SSL; X-ray; 1.45 A; A=2-238.
DR   PDB; 3SSP; X-ray; 1.63 A; A=2-238.
DR   PDB; 3SST; X-ray; 1.40 A; A=2-238.
DR   PDB; 3SSV; X-ray; 1.86 A; A=2-238.
DR   PDB; 3SSY; X-ray; 1.77 A; A=2-238.
DR   PDB; 3ST0; X-ray; 1.19 A; A=2-238.
DR   PDB; 3SV5; X-ray; 1.53 A; A=2-238.
DR   PDB; 3SVB; X-ray; 1.30 A; A=2-238.
DR   PDB; 3SVC; X-ray; 1.31 A; A=2-238.
DR   PDB; 3SVD; X-ray; 1.78 A; A=2-238.
DR   PDB; 3SVE; X-ray; 1.49 A; A=2-238.
DR   PDB; 3U8P; X-ray; 2.75 A; A/B/C=2-238.
DR   PDB; 3UFZ; X-ray; 1.85 A; A=2-229.
DR   PDB; 3UG0; X-ray; 2.09 A; A=2-229.
DR   PDB; 3V3D; X-ray; 1.95 A; A=2-238.
DR   PDB; 3VHT; X-ray; 2.40 A; A=1-230.
DR   PDB; 3W1C; X-ray; 1.30 A; A=2-238.
DR   PDB; 3W1D; X-ray; 1.50 A; A=2-238.
DR   PDB; 3WLC; X-ray; 2.49 A; A=2-238.
DR   PDB; 3WLD; X-ray; 2.70 A; A=2-144.
DR   PDB; 3ZTF; X-ray; 1.31 A; A=2-238.
DR   PDB; 4ANJ; X-ray; 2.60 A; A=1-238.
DR   PDB; 4AR7; X-ray; 1.23 A; A=2-238.
DR   PDB; 4AS8; X-ray; 1.02 A; A=2-238.
DR   PDB; 4B5Y; X-ray; 1.45 A; A=2-238.
DR   PDB; 4BDU; X-ray; 3.00 A; A/B/C/D=1-230.
DR   PDB; 4EN1; X-ray; 1.62 A; A/B=2-238.
DR   PDB; 4EUL; X-ray; 1.35 A; A=2-238.
DR   PDB; 4GES; X-ray; 1.23 A; B=1-238.
DR   PDB; 4GF6; X-ray; 1.10 A; B=1-237.
DR   PDB; 4H47; X-ray; 1.90 A; A=1-238.
DR   PDB; 4H48; X-ray; 1.45 A; A=1-238.
DR   PDB; 4IK1; X-ray; 2.00 A; A=2-144.
DR   PDB; 4IK3; X-ray; 2.01 A; A=149-238, A=2-142.
DR   PDB; 4IK4; X-ray; 2.01 A; A=2-142, A=149-238.
DR   PDB; 4IK5; X-ray; 2.50 A; A=2-142, A=149-238.
DR   PDB; 4IK8; X-ray; 1.55 A; A=2-144, A=149-238.
DR   PDB; 4IK9; X-ray; 1.80 A; A=2-144.
DR   PDB; 4J88; X-ray; 2.08 A; A/B=2-238.
DR   PDB; 4J89; X-ray; 2.10 A; A/B=2-238.
DR   PDB; 4J8A; X-ray; 1.26 A; A=2-238.
DR   PDB; 4JFG; X-ray; 3.00 A; A/B/C/D/E/F/G/H=1-238.
DR   PDB; 4JRB; X-ray; 2.41 A; A=1-229.
DR   PDB; 4KA9; X-ray; 1.58 A; A=5-238.
DR   PDB; 4KAG; X-ray; 1.12 A; A=1-238.
DR   PDB; 4KEX; X-ray; 1.60 A; A=1-238.
DR   PDB; 4KF5; X-ray; 2.60 A; A/B=1-196.
DR   PDB; 4KW4; X-ray; 1.75 A; A=2-238.
DR   PDB; 4KW8; X-ray; 2.46 A; A=2-238.
DR   PDB; 4KW9; X-ray; 1.80 A; A=2-238.
DR   PDB; 4L12; X-ray; 1.78 A; A=2-230.
DR   PDB; 4L13; X-ray; 1.66 A; A=2-230.
DR   PDB; 4L1I; X-ray; 1.20 A; A=2-230.
DR   PDB; 4LQT; X-ray; 1.10 A; A=2-238.
DR   PDB; 4LQU; X-ray; 1.60 A; A/B/C/D=2-238.
DR   PDB; 4LW5; X-ray; 2.55 A; A/B/C/D/E=2-238.
DR   PDB; 4N3D; X-ray; 1.34 A; A/B=1-230.
DR   PDB; 4NDJ; X-ray; 1.85 A; A=2-238.
DR   PDB; 4NDK; X-ray; 2.30 A; A/B=2-238.
DR   PDB; 4OGS; X-ray; 2.21 A; A/B=1-238.
DR   PDB; 4ORN; X-ray; 1.71 A; A/B=2-238.
DR   PDB; 4P1Q; X-ray; 1.50 A; A=3-231.
DR   PDB; 4P7H; X-ray; 3.20 A; A/B=5-238.
DR   PDB; 4PA0; X-ray; 2.25 A; A/B=5-234.
DR   PDB; 4PFE; X-ray; 2.60 A; A/B=2-229.
DR   PDB; 4U2V; X-ray; 2.30 A; A/B/C/D=1-230.
DR   PDB; 4XBI; X-ray; 2.01 A; A/B=2-230.
DR   PDB; 4XGY; X-ray; 1.49 A; A=2-238.
DR   PDB; 4XL5; X-ray; 2.00 A; A=2-238.
DR   PDB; 4XOV; X-ray; 1.20 A; A=2-238.
DR   PDB; 4XOW; X-ray; 1.25 A; A=2-238.
DR   PDB; 4XVP; X-ray; 3.40 A; A/B/C=2-238.
DR   PDB; 4Z4K; X-ray; 2.80 A; A/B=1-230.
DR   PDB; 4Z4M; X-ray; 2.15 A; A/B=1-230.
DR   PDB; 4ZF3; X-ray; 1.90 A; A/B=51-236.
DR   PDB; 4ZF4; X-ray; 1.82 A; A/B=4-237.
DR   PDB; 4ZF5; X-ray; 1.70 A; A/B=4-237.
DR   PDB; 5AQB; X-ray; 1.37 A; B=2-231.
DR   PDB; 5B61; X-ray; 3.12 A; A/B/C/D/E/F=1-238.
DR   PDB; 5DPG; X-ray; 1.85 A; A=2-238.
DR   PDB; 5DPH; X-ray; 1.42 A; A/B=2-238.
DR   PDB; 5DPI; X-ray; 2.54 A; A/B/C/D/E/F=2-238.
DR   PDB; 5DPJ; X-ray; 2.50 A; A/B/C/D=2-238.
DR   PDB; 5DQB; X-ray; 1.25 A; A=2-238.
DR   PDB; 5DQM; X-ray; 1.30 A; A=2-238.
DR   PDB; 5DRF; X-ray; 1.14 A; A=2-238.
DR   PDB; 5DRG; X-ray; 1.14 A; A=2-238.
DR   PDB; 5DTX; X-ray; 1.45 A; A=1-63, A=65-238.
DR   PDB; 5DTY; X-ray; 1.50 A; A=1-63, A=65-238.
DR   PDB; 5DTZ; X-ray; 1.50 A; A/B/C/D=2-238.
DR   PDB; 5DU0; X-ray; 2.35 A; A/B/C/D=2-238.
DR   PDB; 5EHU; X-ray; 1.45 A; A/B=2-238.
DR   PDB; 5F9G; X-ray; 2.77 A; A=2-144.
DR   PDB; 5FGU; X-ray; 1.90 A; A=1-229.
DR   PDB; 5HBD; X-ray; 1.65 A; A=1-238.
DR   PDB; 5HGE; X-ray; 1.86 A; A=1-238.
DR   PDB; 5HW9; X-ray; 3.00 A; A=1-238.
DR   PDB; 5HZO; X-ray; 2.49 A; A/B=1-235.
DR   PDB; 5J2O; X-ray; 1.50 A; A=2-238.
DR   PDB; 5J3N; X-ray; 2.45 A; A/B=2-238.
DR   PDB; 5JZK; X-ray; 1.90 A; A/B=3-238.
DR   PDB; 5JZL; X-ray; 1.80 A; A/B=3-238.
DR   PDB; 5KTG; X-ray; 2.80 A; A/B=1-230.
DR   PDB; 5LEL; X-ray; 3.10 A; C/F/I=2-238.
DR   PDB; 5LEM; X-ray; 2.98 A; C=2-238.
DR   PDB; 5MA3; X-ray; 1.70 A; B=2-238.
DR   PDB; 5MA4; X-ray; 1.40 A; B=2-238.
DR   PDB; 5MA5; X-ray; 1.85 A; B/D=2-238.
DR   PDB; 5MA6; X-ray; 2.30 A; A=2-238.
DR   PDB; 5MA8; X-ray; 2.35 A; B/D=2-238.
DR   PDB; 5MA9; X-ray; 1.57 A; B/D/F/H=2-238.
DR   PDB; 5MAD; X-ray; 1.53 A; B/D/F/H=2-238.
DR   PDB; 5MAK; X-ray; 2.50 A; B/D=2-238.
DR   PDB; 5MSE; X-ray; 1.66 A; A/B/C/D=2-238.
DR   PDB; 5N9O; X-ray; 1.53 A; A=2-238.
DR   PDB; 5NHN; X-ray; 1.96 A; A/B=3-231.
DR   PDB; 5NI3; X-ray; 1.28 A; A=3-229, B/C/D=3-233.
DR   PDB; 5O89; X-ray; 1.70 A; A=2-238.
DR   PDB; 5O8B; X-ray; 1.70 A; A=2-238.
DR   PDB; 5O8C; X-ray; 1.70 A; A=2-238.
DR   PDB; 5OX8; X-ray; 1.29 A; A=2-238.
DR   PDB; 5OX9; X-ray; 1.56 A; A=2-238.
DR   PDB; 5OXA; X-ray; 1.16 A; A=2-238.
DR   PDB; 5OXB; X-ray; 1.38 A; A=2-238.
DR   PDB; 5OXC; X-ray; 1.02 A; A=1-238.
DR   PDB; 5T3I; X-ray; 1.60 A; A=2-238.
DR   PDB; 5WJ2; X-ray; 2.41 A; A/B=2-238.
DR   PDB; 5WJ3; X-ray; 1.35 A; A/B=3-238.
DR   PDB; 5WJ4; X-ray; 1.63 A; A/B=3-238.
DR   PDB; 6AA2; X-ray; 2.30 A; A/B/C=2-238.
DR   PDB; 6AA6; X-ray; 2.39 A; A/B=2-238.
DR   PDB; 6AS9; X-ray; 1.75 A; A=1-238.
DR   PDB; 6B7R; X-ray; 1.73 A; A/B=2-214.
DR   PDB; 6B7T; X-ray; 1.91 A; A/B=3-194, A/B=214-237.
DR   PDB; 6B9C; X-ray; 1.70 A; A=3-238.
DR   PDB; 6DQ0; X-ray; 2.05 A; A/B=1-238.
DR   PDB; 6DQ1; X-ray; 1.60 A; A=1-238.
DR   PDB; 6EFR; X-ray; 2.40 A; A=1-145.
DR   PDB; 6FWW; X-ray; 1.13 A; A=2-238.
DR   PDB; 6GEL; X-ray; 2.51 A; A/B=2-227.
DR   PDB; 6GEZ; X-ray; 2.47 A; A/B=2-227.
DR   PDB; 6GO8; X-ray; 1.65 A; A=1-238.
DR   PDB; 6GO9; X-ray; 1.67 A; A=1-238.
DR   PDB; 6GQG; X-ray; 1.79 A; A=1-238.
DR   PDB; 6GQH; X-ray; 2.40 A; A=1-238.
DR   PDB; 6GRM; X-ray; 2.30 A; A=1-238.
DR   PDB; 6IR6; X-ray; 1.64 A; A=2-238.
DR   PDB; 6IR7; X-ray; 1.28 A; A=2-237.
DR   PDB; 6ITC; EM; 3.45 A; G=1-238.
DR   PDB; 6JGH; X-ray; 0.94 A; A=2-231.
DR   PDB; 6JGI; X-ray; 0.85 A; A=2-231.
DR   PDB; 6JGJ; X-ray; 0.78 A; A=2-231.
DR   PDB; 6MB2; EM; 5.00 A; a/b/c/d/e/f/g/h/i/j/k/l/m/n/o=2-229.
DR   PDB; 6MDR; EM; 3.47 A; b/d/f/h/j/l/n/p=1-232.
DR   PDB; 6MKS; EM; 3.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y/Z/a/b/c/d=1-230.
DR   PDB; 6MWQ; EM; 3.00 A; G/H/I/J=2-230.
DR   PDB; 6OFK; X-ray; 1.15 A; A/B=49-237.
DR   PDB; 6OFL; X-ray; 1.25 A; A/B=49-237.
DR   PDB; 6OFM; X-ray; 1.48 A; A/B=49-237.
DR   PDB; 6OFN; X-ray; 1.65 A; A/B=49-237.
DR   PDB; 6OFO; X-ray; 2.60 A; A/B=2-194.
DR   PDB; 6QQ8; X-ray; 1.46 A; A=2-238.
DR   PDB; 6QQ9; X-ray; 1.82 A; A=2-238.
DR   PDB; 6QQA; X-ray; 1.66 A; A=2-238.
DR   PDB; 6QQB; X-ray; 2.45 A; A=2-238.
DR   PDBsum; 1B9C; -.
DR   PDBsum; 1BFP; -.
DR   PDBsum; 1C4F; -.
DR   PDBsum; 1CV7; -.
DR   PDBsum; 1EMA; -.
DR   PDBsum; 1EMB; -.
DR   PDBsum; 1EMC; -.
DR   PDBsum; 1EME; -.
DR   PDBsum; 1EMF; -.
DR   PDBsum; 1EMG; -.
DR   PDBsum; 1EMK; -.
DR   PDBsum; 1EML; -.
DR   PDBsum; 1EMM; -.
DR   PDBsum; 1F09; -.
DR   PDBsum; 1F0B; -.
DR   PDBsum; 1GFL; -.
DR   PDBsum; 1H6R; -.
DR   PDBsum; 1HCJ; -.
DR   PDBsum; 1HUY; -.
DR   PDBsum; 1JBY; -.
DR   PDBsum; 1JBZ; -.
DR   PDBsum; 1JC0; -.
DR   PDBsum; 1JC1; -.
DR   PDBsum; 1KP5; -.
DR   PDBsum; 1KYP; -.
DR   PDBsum; 1KYR; -.
DR   PDBsum; 1KYS; -.
DR   PDBsum; 1MYW; -.
DR   PDBsum; 1Q4A; -.
DR   PDBsum; 1Q4B; -.
DR   PDBsum; 1Q4C; -.
DR   PDBsum; 1Q4D; -.
DR   PDBsum; 1Q4E; -.
DR   PDBsum; 1Q73; -.
DR   PDBsum; 1QXT; -.
DR   PDBsum; 1QY3; -.
DR   PDBsum; 1QYF; -.
DR   PDBsum; 1QYO; -.
DR   PDBsum; 1QYQ; -.
DR   PDBsum; 1RM9; -.
DR   PDBsum; 1RMM; -.
DR   PDBsum; 1RMO; -.
DR   PDBsum; 1RMP; -.
DR   PDBsum; 1RRX; -.
DR   PDBsum; 1S6Z; -.
DR   PDBsum; 1W7S; -.
DR   PDBsum; 1W7T; -.
DR   PDBsum; 1W7U; -.
DR   PDBsum; 1YFP; -.
DR   PDBsum; 1YHG; -.
DR   PDBsum; 1YHH; -.
DR   PDBsum; 1YHI; -.
DR   PDBsum; 1YJ2; -.
DR   PDBsum; 1YJF; -.
DR   PDBsum; 1Z1P; -.
DR   PDBsum; 1Z1Q; -.
DR   PDBsum; 2AH8; -.
DR   PDBsum; 2AHA; -.
DR   PDBsum; 2AWJ; -.
DR   PDBsum; 2AWK; -.
DR   PDBsum; 2AWL; -.
DR   PDBsum; 2AWM; -.
DR   PDBsum; 2B3P; -.
DR   PDBsum; 2B3Q; -.
DR   PDBsum; 2DUE; -.
DR   PDBsum; 2DUF; -.
DR   PDBsum; 2DUG; -.
DR   PDBsum; 2DUH; -.
DR   PDBsum; 2DUI; -.
DR   PDBsum; 2EMD; -.
DR   PDBsum; 2EMN; -.
DR   PDBsum; 2EMO; -.
DR   PDBsum; 2FWQ; -.
DR   PDBsum; 2FZU; -.
DR   PDBsum; 2G16; -.
DR   PDBsum; 2G2S; -.
DR   PDBsum; 2G3D; -.
DR   PDBsum; 2G5Z; -.
DR   PDBsum; 2G6E; -.
DR   PDBsum; 2H6V; -.
DR   PDBsum; 2H9W; -.
DR   PDBsum; 2HCG; -.
DR   PDBsum; 2HFC; -.
DR   PDBsum; 2HGD; -.
DR   PDBsum; 2HGY; -.
DR   PDBsum; 2HJO; -.
DR   PDBsum; 2HQZ; -.
DR   PDBsum; 2HRS; -.
DR   PDBsum; 2JAD; -.
DR   PDBsum; 2O24; -.
DR   PDBsum; 2O29; -.
DR   PDBsum; 2O2B; -.
DR   PDBsum; 2OKW; -.
DR   PDBsum; 2OKY; -.
DR   PDBsum; 2Q57; -.
DR   PDBsum; 2Q6P; -.
DR   PDBsum; 2QRF; -.
DR   PDBsum; 2QT2; -.
DR   PDBsum; 2QU1; -.
DR   PDBsum; 2QZ0; -.
DR   PDBsum; 2WSN; -.
DR   PDBsum; 2WSO; -.
DR   PDBsum; 2WUR; -.
DR   PDBsum; 2Y0G; -.
DR   PDBsum; 2YDZ; -.
DR   PDBsum; 2YE0; -.
DR   PDBsum; 2YE1; -.
DR   PDBsum; 2YFP; -.
DR   PDBsum; 3AI4; -.
DR   PDBsum; 3CB9; -.
DR   PDBsum; 3CBE; -.
DR   PDBsum; 3CD1; -.
DR   PDBsum; 3CD9; -.
DR   PDBsum; 3DPW; -.
DR   PDBsum; 3DPX; -.
DR   PDBsum; 3DPZ; -.
DR   PDBsum; 3DQ1; -.
DR   PDBsum; 3DQ2; -.
DR   PDBsum; 3DQ3; -.
DR   PDBsum; 3DQ4; -.
DR   PDBsum; 3DQ5; -.
DR   PDBsum; 3DQ6; -.
DR   PDBsum; 3DQ7; -.
DR   PDBsum; 3DQ8; -.
DR   PDBsum; 3DQ9; -.
DR   PDBsum; 3DQA; -.
DR   PDBsum; 3DQC; -.
DR   PDBsum; 3DQD; -.
DR   PDBsum; 3DQE; -.
DR   PDBsum; 3DQF; -.
DR   PDBsum; 3DQH; -.
DR   PDBsum; 3DQI; -.
DR   PDBsum; 3DQJ; -.
DR   PDBsum; 3DQK; -.
DR   PDBsum; 3DQL; -.
DR   PDBsum; 3DQM; -.
DR   PDBsum; 3DQN; -.
DR   PDBsum; 3DQO; -.
DR   PDBsum; 3DQU; -.
DR   PDBsum; 3ED8; -.
DR   PDBsum; 3EK4; -.
DR   PDBsum; 3EK7; -.
DR   PDBsum; 3EK8; -.
DR   PDBsum; 3EKH; -.
DR   PDBsum; 3EKJ; -.
DR   PDBsum; 3EVP; -.
DR   PDBsum; 3EVR; -.
DR   PDBsum; 3EVU; -.
DR   PDBsum; 3EVV; -.
DR   PDBsum; 3G9A; -.
DR   PDBsum; 3GEX; -.
DR   PDBsum; 3GJ1; -.
DR   PDBsum; 3GJ2; -.
DR   PDBsum; 3I19; -.
DR   PDBsum; 3K1K; -.
DR   PDBsum; 3LA1; -.
DR   PDBsum; 3O77; -.
DR   PDBsum; 3O78; -.
DR   PDBsum; 3OGO; -.
DR   PDBsum; 3OSQ; -.
DR   PDBsum; 3OSR; -.
DR   PDBsum; 3P28; -.
DR   PDBsum; 3SG2; -.
DR   PDBsum; 3SG3; -.
DR   PDBsum; 3SG4; -.
DR   PDBsum; 3SG5; -.
DR   PDBsum; 3SG6; -.
DR   PDBsum; 3SG7; -.
DR   PDBsum; 3SRY; -.
DR   PDBsum; 3SS0; -.
DR   PDBsum; 3SSH; -.
DR   PDBsum; 3SSK; -.
DR   PDBsum; 3SSL; -.
DR   PDBsum; 3SSP; -.
DR   PDBsum; 3SST; -.
DR   PDBsum; 3SSV; -.
DR   PDBsum; 3SSY; -.
DR   PDBsum; 3ST0; -.
DR   PDBsum; 3SV5; -.
DR   PDBsum; 3SVB; -.
DR   PDBsum; 3SVC; -.
DR   PDBsum; 3SVD; -.
DR   PDBsum; 3SVE; -.
DR   PDBsum; 3U8P; -.
DR   PDBsum; 3UFZ; -.
DR   PDBsum; 3UG0; -.
DR   PDBsum; 3V3D; -.
DR   PDBsum; 3VHT; -.
DR   PDBsum; 3W1C; -.
DR   PDBsum; 3W1D; -.
DR   PDBsum; 3WLC; -.
DR   PDBsum; 3WLD; -.
DR   PDBsum; 3ZTF; -.
DR   PDBsum; 4ANJ; -.
DR   PDBsum; 4AR7; -.
DR   PDBsum; 4AS8; -.
DR   PDBsum; 4B5Y; -.
DR   PDBsum; 4BDU; -.
DR   PDBsum; 4EN1; -.
DR   PDBsum; 4EUL; -.
DR   PDBsum; 4GES; -.
DR   PDBsum; 4GF6; -.
DR   PDBsum; 4H47; -.
DR   PDBsum; 4H48; -.
DR   PDBsum; 4IK1; -.
DR   PDBsum; 4IK3; -.
DR   PDBsum; 4IK4; -.
DR   PDBsum; 4IK5; -.
DR   PDBsum; 4IK8; -.
DR   PDBsum; 4IK9; -.
DR   PDBsum; 4J88; -.
DR   PDBsum; 4J89; -.
DR   PDBsum; 4J8A; -.
DR   PDBsum; 4JFG; -.
DR   PDBsum; 4JRB; -.
DR   PDBsum; 4KA9; -.
DR   PDBsum; 4KAG; -.
DR   PDBsum; 4KEX; -.
DR   PDBsum; 4KF5; -.
DR   PDBsum; 4KW4; -.
DR   PDBsum; 4KW8; -.
DR   PDBsum; 4KW9; -.
DR   PDBsum; 4L12; -.
DR   PDBsum; 4L13; -.
DR   PDBsum; 4L1I; -.
DR   PDBsum; 4LQT; -.
DR   PDBsum; 4LQU; -.
DR   PDBsum; 4LW5; -.
DR   PDBsum; 4N3D; -.
DR   PDBsum; 4NDJ; -.
DR   PDBsum; 4NDK; -.
DR   PDBsum; 4OGS; -.
DR   PDBsum; 4ORN; -.
DR   PDBsum; 4P1Q; -.
DR   PDBsum; 4P7H; -.
DR   PDBsum; 4PA0; -.
DR   PDBsum; 4PFE; -.
DR   PDBsum; 4U2V; -.
DR   PDBsum; 4XBI; -.
DR   PDBsum; 4XGY; -.
DR   PDBsum; 4XL5; -.
DR   PDBsum; 4XOV; -.
DR   PDBsum; 4XOW; -.
DR   PDBsum; 4XVP; -.
DR   PDBsum; 4Z4K; -.
DR   PDBsum; 4Z4M; -.
DR   PDBsum; 4ZF3; -.
DR   PDBsum; 4ZF4; -.
DR   PDBsum; 4ZF5; -.
DR   PDBsum; 5AQB; -.
DR   PDBsum; 5B61; -.
DR   PDBsum; 5DPG; -.
DR   PDBsum; 5DPH; -.
DR   PDBsum; 5DPI; -.
DR   PDBsum; 5DPJ; -.
DR   PDBsum; 5DQB; -.
DR   PDBsum; 5DQM; -.
DR   PDBsum; 5DRF; -.
DR   PDBsum; 5DRG; -.
DR   PDBsum; 5DTX; -.
DR   PDBsum; 5DTY; -.
DR   PDBsum; 5DTZ; -.
DR   PDBsum; 5DU0; -.
DR   PDBsum; 5EHU; -.
DR   PDBsum; 5F9G; -.
DR   PDBsum; 5FGU; -.
DR   PDBsum; 5HBD; -.
DR   PDBsum; 5HGE; -.
DR   PDBsum; 5HW9; -.
DR   PDBsum; 5HZO; -.
DR   PDBsum; 5J2O; -.
DR   PDBsum; 5J3N; -.
DR   PDBsum; 5JZK; -.
DR   PDBsum; 5JZL; -.
DR   PDBsum; 5KTG; -.
DR   PDBsum; 5LEL; -.
DR   PDBsum; 5LEM; -.
DR   PDBsum; 5MA3; -.
DR   PDBsum; 5MA4; -.
DR   PDBsum; 5MA5; -.
DR   PDBsum; 5MA6; -.
DR   PDBsum; 5MA8; -.
DR   PDBsum; 5MA9; -.
DR   PDBsum; 5MAD; -.
DR   PDBsum; 5MAK; -.
DR   PDBsum; 5MSE; -.
DR   PDBsum; 5N9O; -.
DR   PDBsum; 5NHN; -.
DR   PDBsum; 5NI3; -.
DR   PDBsum; 5O89; -.
DR   PDBsum; 5O8B; -.
DR   PDBsum; 5O8C; -.
DR   PDBsum; 5OX8; -.
DR   PDBsum; 5OX9; -.
DR   PDBsum; 5OXA; -.
DR   PDBsum; 5OXB; -.
DR   PDBsum; 5OXC; -.
DR   PDBsum; 5T3I; -.
DR   PDBsum; 5WJ2; -.
DR   PDBsum; 5WJ3; -.
DR   PDBsum; 5WJ4; -.
DR   PDBsum; 6AA2; -.
DR   PDBsum; 6AA6; -.
DR   PDBsum; 6AS9; -.
DR   PDBsum; 6B7R; -.
DR   PDBsum; 6B7T; -.
DR   PDBsum; 6B9C; -.
DR   PDBsum; 6DQ0; -.
DR   PDBsum; 6DQ1; -.
DR   PDBsum; 6EFR; -.
DR   PDBsum; 6FWW; -.
DR   PDBsum; 6GEL; -.
DR   PDBsum; 6GEZ; -.
DR   PDBsum; 6GO8; -.
DR   PDBsum; 6GO9; -.
DR   PDBsum; 6GQG; -.
DR   PDBsum; 6GQH; -.
DR   PDBsum; 6GRM; -.
DR   PDBsum; 6IR6; -.
DR   PDBsum; 6IR7; -.
DR   PDBsum; 6ITC; -.
DR   PDBsum; 6JGH; -.
DR   PDBsum; 6JGI; -.
DR   PDBsum; 6JGJ; -.
DR   PDBsum; 6MB2; -.
DR   PDBsum; 6MDR; -.
DR   PDBsum; 6MKS; -.
DR   PDBsum; 6MWQ; -.
DR   PDBsum; 6OFK; -.
DR   PDBsum; 6OFL; -.
DR   PDBsum; 6OFM; -.
DR   PDBsum; 6OFN; -.
DR   PDBsum; 6OFO; -.
DR   PDBsum; 6QQ8; -.
DR   PDBsum; 6QQ9; -.
DR   PDBsum; 6QQA; -.
DR   PDBsum; 6QQB; -.
DR   SMR; P42212; -.
DR   IntAct; P42212; 1.
DR   PRIDE; P42212; -.
DR   ABCD; P42212; -.
DR   BioCyc; MetaCyc:MONOMER-20291; -.
DR   EvolutionaryTrace; P42212; -.
DR   GO; GO:0008218; P:bioluminescence; TAS:UniProtKB.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:UniProtKB.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   InterPro; IPR009017; GFP.
DR   InterPro; IPR011584; GFP-related.
DR   InterPro; IPR000786; Green_fluorescent_prot.
DR   Pfam; PF01353; GFP; 1.
DR   PRINTS; PR01229; GFLUORESCENT.
DR   SUPFAM; SSF54511; SSF54511; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromophore; Direct protein sequencing; Luminescence;
KW   Photoprotein.
FT   CHAIN           1..238
FT                   /note="Green fluorescent protein"
FT                   /id="PRO_0000192576"
FT   MOD_RES         66
FT                   /note="(Z)-2,3-didehydrotyrosine"
FT                   /evidence="ECO:0000269|PubMed:8448132"
FT   CROSSLNK        65..67
FT                   /note="5-imidazolinone (Ser-Gly)"
FT                   /evidence="ECO:0000269|PubMed:8448132"
FT   VARIANT         100
FT                   /note="F -> Y"
FT                   /evidence="ECO:0000269|PubMed:1347277"
FT   VARIANT         108
FT                   /note="T -> S"
FT                   /evidence="ECO:0000269|PubMed:1347277"
FT   VARIANT         141
FT                   /note="L -> M"
FT                   /evidence="ECO:0000269|PubMed:1347277"
FT   VARIANT         219
FT                   /note="V -> I"
FT                   /evidence="ECO:0000269|PubMed:1347277"
FT   MUTAGEN         30
FT                   /note="S->R: In mut1.28; shifts fluorescence lifetime from
FT                   3.03 to 2.76 ns; when associated with H-145. In mut2.2;
FT                   shifts fluorescence lifetime from 3.03 to 1.94 ns; when
FT                   associated with H-69 and H-145. In mut3.3; shifts
FT                   fluorescence lifetime from 3.03 to 1.88 ns; when associated
FT                   with L-46; H-69 and H-145. In EBFP1.2; shifts the
FT                   excitation and emission spectra to shorter wavelengths and
FT                   increases quantum yields compared to BFP; when associated
FT                   with N-39; H-66; A-72; T-105; F-145; V-171; S-198 and V-
FT                   206. In EBFP2.0; shifts the excitation and emission spectra
FT                   to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with N-39; H-66; A-72; T-
FT                   105; V-128; F-145; I-150; V-155; V-171; S-198; V-206 and V-
FT                   224."
FT                   /evidence="ECO:0000269|PubMed:16201762,
FT                   ECO:0000269|PubMed:22891786"
FT   MUTAGEN         39
FT                   /note="Y->N: In EBFP1.2; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; H-66; A-72; T-
FT                   105; F-145; V-171; S-198 and V-206. In EBFP2.0; shifts the
FT                   excitation and emission spectra to shorter wavelengths and
FT                   increases quantum yields compared to BFP; when associated
FT                   with R-30; H-66; A-72; T-105; V-128; F-145; I-150; V-155;
FT                   V-171; S-198; V-206 and V-224."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   MUTAGEN         46
FT                   /note="F->L: In mut3.3; shifts fluorescence lifetime from
FT                   3.03 to 1.88 ns; when associated with R-30; H-69 and H-145.
FT                   In R10-3; matures to the red-emitting state with excitation
FT                   and emission maxima at 555 and 585 nm, respectively; when
FT                   associated with L-64; N-68; Q-162; A-163; V-167 and L-171.
FT                   In Venus; leads to yellow fluorescence, improved maturation
FT                   and reduced environmental sensitivity; when associated with
FT                   L-64; G-65; L-68; A-72; T-153; A-163; G-175 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:12370172,
FT                   ECO:0000269|PubMed:16201762, ECO:0000269|PubMed:18366185"
FT   MUTAGEN         64
FT                   /note="F->L: In EGFP; increases fluoresence at warmer
FT                   temperatures such as 37 degrees Celsius; when associated
FT                   with T-65. In EBFP; gives rise to variants with blue
FT                   fluorescence; when associated with T-65 and H-66. In ECFP;
FT                   leads to cyan fluorescence, folds faster and more
FT                   efficiently at 37 degrees Celsius and has superior
FT                   solubility and brightness; when associated with T-65; W-66;
FT                   I-146; T-153 and A-163. In Cerulean; leads to improved
FT                   quantum yield, a higher extinction coefficient and is 2.5-
FT                   fold brighterH than ECFP; when associated with T-65; W-66;
FT                   A-72; A-145; I-146; D-148; T-153 and A-163. In R10-3;
FT                   matures to the red-emitting state with excitation and
FT                   emission maxima at 555 and 585 nm, respectively; when
FT                   associated with L-46; N-68; Q-162; A-163; V-167 and L-171.
FT                   In GFPmut 1; red-shifts by about 100 nm the excitation
FT                   maxima, permitting efficient excitation at 488 nm and
FT                   increases fluorescence; when associated with T-65. In
FT                   VisGreen; leads to brighter fluorescence; when associated
FT                   with T-65; A-72; K-149 and T-167. In Venus; leads to yellow
FT                   fluorescence, improved maturation and reduced environmental
FT                   sensitivity; when associated with L-46; G-65; L-68; A-72;
FT                   T-153; A-163; G-175 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:11776264, ECO:0000269|PubMed:12370172,
FT                   ECO:0000269|PubMed:14990965, ECO:0000269|PubMed:15065907,
FT                   ECO:0000269|PubMed:17658219, ECO:0000269|PubMed:18366185,
FT                   ECO:0000269|PubMed:8707053, ECO:0000269|PubMed:9145105,
FT                   ECO:0000269|PubMed:9370472"
FT   MUTAGEN         64
FT                   /note="F->M: In RSGFP4; increases fluorescence and shifts
FT                   the major exitation peak to 489-490 nm; when associated
FT                   with G-65 and L-69."
FT                   /evidence="ECO:0000269|PubMed:9634755"
FT   MUTAGEN         65..66
FT                   /note="SY->TW: Gives rise to variants with cerulean
FT                   fluorsecence."
FT                   /evidence="ECO:0000269|PubMed:17685554"
FT   MUTAGEN         65
FT                   /note="S->A: In GFPmut 2; red-shifts by about 100 nm the
FT                   excitation maxima, permitting efficient excitation at 488
FT                   nm and increases fluorescence; when associated with L-68
FT                   and A-72."
FT                   /evidence="ECO:0000269|PubMed:8707053"
FT   MUTAGEN         65
FT                   /note="S->G: In EYFP; leads to yellow fluorescence, folds
FT                   faster and more efficiently at 37 degrees Celsius and has
FT                   superior solubility and brightness; when associated with L-
FT                   68; A-72 and Y-203. In GFPmut 3; highly fluorescent mutant
FT                   when excited at 488 nm; when associated with A-72. Highly
FT                   fluorescent; when associated with Y-203; L-68 and A-72. In
FT                   RSGFP4; increases fluoresence and shifts the major
FT                   exitation peak to 489-490 nm; when associated with M-64 and
FT                   L-69. In YFP 10C; shifts the major emission and exitation
FT                   peak up to 20 nm; when associated with L-68; A-72 and Y-
FT                   203. In Topaz; shifts the major emission and exitation peak
FT                   up to 20 nm; when associated with A-72; R-79 and Y-203. In
FT                   Venus; leads to yellow fluorescence, improved maturation
FT                   and reduced environmental sensitivity; when associated with
FT                   L-46; L-64; L-68; A-72; T-153; A-163; G-175 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:12370172, ECO:0000269|PubMed:8707053,
FT                   ECO:0000269|PubMed:9634755, ECO:0000269|PubMed:9759496,
FT                   ECO:0000269|PubMed:9782051"
FT   MUTAGEN         65
FT                   /note="S->T: Increases fluoresence, photostability and
FT                   shifts the major exitation peak to 488 nm. In EGFP;
FT                   increases fluoresence at warmer temperatures such as 37
FT                   degrees Celsius; when associated with L-64. In EBFP; gives
FT                   rise to variants with blue fluorescence; when associated
FT                   with L-64 and H-66. In GFPmut 1; red-shifts by about 100 nm
FT                   the excitation maxima, permitting efficient excitation at
FT                   488 nm and increases fluorescence; when associated with T-
FT                   65. In ECFP; leads to cyan fluorescence, folds faster and
FT                   more efficiently at 37 degrees Celsius and has superior
FT                   solubility and brightness; when associated with L-64; W-66;
FT                   I-146; T-153 and A-163. In Cerulean; leads to improved
FT                   quantum yield, a higher extinction coefficient and is 2.5-
FT                   fold brighter than ECFP; when associated with L-64; W-66;
FT                   A-72; A-145; I-146; D-148; T-153 and A-163. In Esmerald;
FT                   leads to brighter fluorescence; when associated with A-72;
FT                   K-149; T-153 and T-167. In VisGreen; leads to brighter
FT                   fluorescence; when associated with L-64; A-72; K-149 and T-
FT                   167."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:11776264, ECO:0000269|PubMed:14990965,
FT                   ECO:0000269|PubMed:15065907, ECO:0000269|PubMed:17658219,
FT                   ECO:0000269|PubMed:8703075, ECO:0000269|PubMed:8707053,
FT                   ECO:0000269|PubMed:9370472"
FT   MUTAGEN         66
FT                   /note="Y->H: In BFP; shifts the excitation and emission
FT                   spectra to shorter wavelengths. In EBFP; gives rise to
FT                   variants with blue fluorescence; when associated with L-64
FT                   and T-65. In Azurite; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-80; F-145; I-150
FT                   and R-224. In EBFP1.2; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; A-72; T-
FT                   105; F-145; V-171; S-198 and V-206. In EBFP2.0; shifts the
FT                   excitation and emission spectra to shorter wavelengths and
FT                   increases quantum yields compared to BFP; when associated
FT                   with R-30; N-39; A-72; T-105; V-128; F-145; I-150; V-155;
FT                   V-171; S-198; V-206 and V-224."
FT                   /evidence="ECO:0000269|PubMed:22891786,
FT                   ECO:0000269|PubMed:8578587, ECO:0000269|PubMed:9145105,
FT                   ECO:0000269|PubMed:9370472"
FT   MUTAGEN         66
FT                   /note="Y->T,F: Shifts the excitation and emission spectra
FT                   to shorter wavelengths."
FT                   /evidence="ECO:0000269|PubMed:8578587"
FT   MUTAGEN         66
FT                   /note="Y->W: In W; leads to excitation and emission
FT                   wavelengths intermediate between tyrosine and histidine but
FT                   is only weakly fluorescent. In ECFP; leads to cyan
FT                   fluorescence, folds faster and more efficiently at 37
FT                   degrees Celsius and has superior solubility and brightness;
FT                   when associated with L-64; T-65; I-146; T-153 and A-163. In
FT                   Cerulean; leads to improved quantum yield, a higher
FT                   extinction coefficient and is 2.5-fold brighter than ECFP;
FT                   when associated with L-64; T-65; A-72; A-145; I-146; D-148;
FT                   T-153 and A-163."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:14990965, ECO:0000269|PubMed:15065907,
FT                   ECO:0000269|PubMed:7809066"
FT   MUTAGEN         68
FT                   /note="V->L: In EYFP; leads to yellow fluorescence, folds
FT                   faster and more efficiently at 37 degrees Celsius and has
FT                   superior solubility and brightness; when associated with G-
FT                   65; A-72 and Y-203. In GFPmut 2; red-shifts by about 100 nm
FT                   the excitation maxima, permitting efficient excitation at
FT                   488 nm and increases fluorescence; when associated with A-
FT                   65 and A-72. In Citrinine; leads to excitation and emission
FT                   peaks of 516 and 529 nm, respectively; when associated with
FT                   M-69; A-72 and Y-203. In YFP 10C; shifts the major emission
FT                   and exitation peak up to 20 nm; when associated with G-65;
FT                   A-72 and Y-203. In Venus; leads to yellow fluorescence,
FT                   improved maturation and reduced environmental sensitivity;
FT                   when associated with L-46; L-64; G-65; A-72; T-153; A-163;
FT                   G-175 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:11387331, ECO:0000269|PubMed:12370172,
FT                   ECO:0000269|PubMed:8707053, ECO:0000269|PubMed:9759496,
FT                   ECO:0000269|PubMed:9782051"
FT   MUTAGEN         68
FT                   /note="V->N: In R10-3; matures to the red-emitting state
FT                   with excitation and emission maxima at 555 and 585 nm,
FT                   respectively; when associated with L-46; L-64; Q-162; A-
FT                   163; V-167 and L-171."
FT                   /evidence="ECO:0000269|PubMed:18366185"
FT   MUTAGEN         69
FT                   /note="Q->H: In P4; leads to no detectable fluorescence. In
FT                   mut2.2; shifts fluorescence lifetime from 3.03 to 1.94 ns;
FT                   when associated with R-30 and H-145. In mut3.3; shifts
FT                   fluorescence lifetime from 3.03 to 1.88 ns; when associated
FT                   with R-30; L-46 and H-145."
FT                   /evidence="ECO:0000269|PubMed:16201762,
FT                   ECO:0000269|PubMed:7809066"
FT   MUTAGEN         69
FT                   /note="Q->L: In RSGFP4; increases fluorescence and shifts
FT                   the major exitation peak to 489-490 nm; when associated
FT                   with M-64 and G-65."
FT                   /evidence="ECO:0000269|PubMed:9634755"
FT   MUTAGEN         69
FT                   /note="Q->M: In Citrinine; leads to excitation and emission
FT                   peaks of 516 and 529 nm, respectively; when associated with
FT                   L-68; A-72 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:11387331"
FT   MUTAGEN         72
FT                   /note="S->A: Increases fluoresence at warmer temperatures
FT                   such as 37 degrees Celsius. In GFPmut 3; highly fluorescent
FT                   mutant when excited at 488 nm; when associated with G-65.
FT                   In EYFP; leads to yellow fluorescence, folds faster and
FT                   more efficiently at 37 degrees Celsius and has superior
FT                   solubility and brightness; when associated with G-65; L-68
FT                   and Y-203. In GFPmut 2; red-shifts by about 100 nm the
FT                   excitation maxima, permitting efficient excitation at 488
FT                   nm and increases fluorescence; when associated with A-65
FT                   and L-68. In Citrinine; leads to excitation and emission
FT                   peaks of 516 and 529 nm, respectively; when associated with
FT                   L-68; M-69 and Y-203. In YFP 10C; shifts the major emission
FT                   and exitation peak up to 20 nm; when associated with G-65;
FT                   L-68; and Y-203. In Topaz; shifts the major emission and
FT                   exitation peak up to 20 nm; when associated with G-65; R-79
FT                   and Y-203. In Cerulean; leads to improved quantum yield, a
FT                   higher extinction coefficient and is 2.5-fold brighter than
FT                   ECFP; when associated with L-64; T-65; W-66; A-145; I-146;
FT                   D-148; T-153 and A-163. In Sapphire/H9-40; exhibits a huge
FT                   Stoke's shift, with an excitation peak at 399 nm and an
FT                   emission peak at 511 nm; when associated with F-145 and I-
FT                   203. In EBFP1.2; shifts the excitation and emission spectra
FT                   to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; T-
FT                   105; F-145; V-171; S-198 and V-206. In EBFP2.0; shifts the
FT                   excitation and emission spectra to shorter wavelengths and
FT                   increases quantum yields compared to BFP; when associated
FT                   with R-30; N-39; H-66; T-105; V-128; F-145; I-150; V-155;
FT                   V-171; S-198; V-206 and V-224. In Esmerald; leads to
FT                   brighter fluorescence; when associated with T-65; K-149; T-
FT                   153 and T-167. In VisGreen; leads to brighter fluorescence;
FT                   when associated with L-64; T-65; K-149 and T-167. In Venus;
FT                   leads to yellow fluorescence, improved maturation and
FT                   reduced environmental sensitivity; when associated with L-
FT                   46; L-64; G-65; L-68; T-153; A-163; G-175 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:11387331, ECO:0000269|PubMed:12370172,
FT                   ECO:0000269|PubMed:12769828, ECO:0000269|PubMed:14990965,
FT                   ECO:0000269|PubMed:17658219, ECO:0000269|PubMed:22891786,
FT                   ECO:0000269|PubMed:8707053, ECO:0000269|PubMed:9145105,
FT                   ECO:0000269|PubMed:9759496, ECO:0000269|PubMed:9782051"
FT   MUTAGEN         79
FT                   /note="K->R: In Topaz; shifts the major emission and
FT                   exitation peak up to 20 nm; when associated with G-65; A-72
FT                   and Y-203."
FT                   /evidence="ECO:0000269|PubMed:9759496"
FT   MUTAGEN         80
FT                   /note="Q->R: In Azurite; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with H-66; F-145; I-150
FT                   and R-224."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   MUTAGEN         99
FT                   /note="F->S: In alphaGFP/cycle 3 GFP; improves folding at
FT                   37 degrees Celsius, reduces aggregation at high
FT                   concentrations, and increases the diffusibility of the
FT                   protein inside cells; when associated with T-153 and A-
FT                   163."
FT                   /evidence="ECO:0000269|PubMed:9370472,
FT                   ECO:0000269|PubMed:9630892, ECO:0000269|PubMed:9631088"
FT   MUTAGEN         103
FT                   /note="D->E: In mut1.27; shifts fluorescence lifetime from
FT                   3.03 to 2.85 ns; when associated with H-145."
FT                   /evidence="ECO:0000269|PubMed:16201762"
FT   MUTAGEN         105
FT                   /note="N->T: In EBFP1.2; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; A-
FT                   72; F-145; V-171; S-198 and V-206. In EBFP2.0; shifts the
FT                   excitation and emission spectra to shorter wavelengths and
FT                   increases quantum yields compared to BFP; when associated
FT                   with R-30; N-39; H-66; A-72; V-128; F-145; I-150; V-155; V-
FT                   171; S-198; V-206 and V-224."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   MUTAGEN         128
FT                   /note="I->V: In EBFP2.0; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; A-
FT                   72; T-105; F-145; I-150; V-155; V-171; S-198; V-206 and V-
FT                   224."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   MUTAGEN         145
FT                   /note="Y->A: In Cerulean; leads to improved quantum yield,
FT                   a higher extinction coefficient and is 2.5-fold brighter
FT                   than ECFP; when associated with L-64; T-65; W-66; A-72; I-
FT                   146; D-148; T-153 and A-163."
FT                   /evidence="ECO:0000269|PubMed:14990965"
FT   MUTAGEN         145
FT                   /note="Y->C: In mut1.9; shifts fluorescence lifetime from
FT                   3.03 to 2.74 ns."
FT                   /evidence="ECO:0000269|PubMed:16201762"
FT   MUTAGEN         145
FT                   /note="Y->F: In Sapphire/H9-40; exhibits a huge Stoke's
FT                   shift, with an excitation peak at 399 nm and an emission
FT                   peak at 511 nm; when associated with A-72 and I-203. In
FT                   Azurite; shifts the excitation and emission spectra to
FT                   shorter wavelengths and increases quantum yields compared
FT                   to BFP; when associated with H-66; R-80; I-150 and R-224.
FT                   In EBFP1.2; shifts the excitation and emission spectra to
FT                   shorter wavelengths and increases quantum yields compared
FT                   to BFP; when associated with R-30; N-39; H-66; A-72; T-105;
FT                   V-171; S-198 and V-206. In EBFP2.0; shifts the excitation
FT                   and emission spectra to shorter wavelengths and increases
FT                   quantum yields compared to BFP; when associated with R-30;
FT                   N-39; H-66; A-72; T-105; V-128; I-150; V-155; V-171; S-198;
FT                   V-206 and V-224."
FT                   /evidence="ECO:0000269|PubMed:12769828,
FT                   ECO:0000269|PubMed:22891786"
FT   MUTAGEN         145
FT                   /note="Y->H: In mut1.3; shifts fluorescence lifetime from
FT                   3.03 to 2.78 ns. In mut1.5; shifts fluorescence lifetime
FT                   from 3.03 to 2.72 ns; when associated with A-193. In
FT                   mut1.27; shifts fluorescence lifetime from 3.03 to 2.85 ns;
FT                   when associated with E-103. In mut1.28; shifts fluorescence
FT                   lifetime from 3.03 to 2.76 ns; when associated with R-30.
FT                   In mut2.1; shifts fluorescence lifetime from 3.03 to 2.50
FT                   ns; when associated with A-176 and I-198. In mut2.2; shifts
FT                   fluorescence lifetime from 3.03 to 1.94 ns; when associated
FT                   with R-30 and H-69. In mut3.3; shifts fluorescence lifetime
FT                   from 3.03 to 1.88 ns; when associated with R-30; L-46 and
FT                   H-69."
FT                   /evidence="ECO:0000269|PubMed:16201762"
FT   MUTAGEN         146
FT                   /note="N->I: In ECFP; leads to cyan fluorescence, folds
FT                   faster and more efficiently at 37 degrees Celsius and has
FT                   superior solubility and brightness; when associated with L-
FT                   64; T-65; W-66; T-153 and A-163. In Cerulean; leads to
FT                   improved quantum yield, a higher extinction coefficient and
FT                   is 2.5-fold brighter than ECFP; when associated with L-64;
FT                   T-65; W-66; A-72; A-145; D-148; T-153 and A-163."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:14990965, ECO:0000269|PubMed:15065907"
FT   MUTAGEN         147
FT                   /note="S->P: Increases fluorescence at warmer temperatures
FT                   such as 37 degrees Celsius."
FT                   /evidence="ECO:0000269|PubMed:9125154"
FT   MUTAGEN         148
FT                   /note="H->D: In Cerulean; leads to improved quantum yield,
FT                   a higher extinction coefficient and is 2.5-fold brighter
FT                   than ECFP; when associated with L-64; T-65; W-66; A-72; A-
FT                   145; I-146; T-153 and A-163."
FT                   /evidence="ECO:0000269|PubMed:14990965"
FT   MUTAGEN         149
FT                   /note="N->K: Increases fluorescence at warmer temperatures
FT                   such as 37 degrees Celsius. In Esmerald; leads to brighter
FT                   fluorescence; when associated with T-65; A-72; T-153 and T-
FT                   167. In VisGreen; leads to brighter fluorescence; when
FT                   associated with L-64; T-65; A-72 and T-167."
FT                   /evidence="ECO:0000269|PubMed:17658219,
FT                   ECO:0000269|PubMed:9145105"
FT   MUTAGEN         150
FT                   /note="V->I: In Azurite; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with H-66; R-80; F-145 and
FT                   R-224. In EBFP2.0; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; A-
FT                   72; T-105; V-128; F-145; V-155; V-171; S-198; V-206 and V-
FT                   224."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   MUTAGEN         153
FT                   /note="M->T: Increases fluorescence at warmer temperatures
FT                   such as 37 degrees Celsius. In alphaGFP/cycle 3 GFP;
FT                   improves folding at 37 degrees Celsius, reduces aggregation
FT                   at high concentrations, and increases the diffusibility of
FT                   the protein inside cells; when associated with S-99 and A-
FT                   163. In ECFP; leads to cyan fluorescence, folds faster and
FT                   more efficiently at 37 degrees Celsius and has superior
FT                   solubility and brightness; when associated with L-64; T-65;
FT                   W-66; I-146 and A-163. In Cerulean; leads to improved
FT                   quantum yield, a higher extinction coefficient and is 2.5-
FT                   fold brighter than ECFP; when associated with L-64; T-65;
FT                   W-66; A-72; A-145; I-146; D-148 and A-163. In Esmerald;
FT                   leads to brighter fluorescence; when associated with T-65;
FT                   A-72; K-149 and T-167. In Venus; leads to yellow
FT                   fluorescence, improved maturation and reduced environmental
FT                   sensitivity; when associated with L-46; L-64; G-65; L-68;
FT                   A-72; A-163; G-175 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:12370172, ECO:0000269|PubMed:14990965,
FT                   ECO:0000269|PubMed:15065907, ECO:0000269|PubMed:17658219,
FT                   ECO:0000269|PubMed:9145105, ECO:0000269|PubMed:9370472,
FT                   ECO:0000269|PubMed:9630892, ECO:0000269|PubMed:9631088"
FT   MUTAGEN         155
FT                   /note="D->V: In EBFP2.0; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; A-
FT                   72; T-105; V-128; F-145; I-150; V-171; S-198; V-206 and V-
FT                   224."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   MUTAGEN         162
FT                   /note="K->Q: In R10-3; matures to the red-emitting state
FT                   with excitation and emission maxima at 555 and 585 nm,
FT                   respectively; when associated with L-46; L-64; N-68; A-163;
FT                   V-167 and L-171."
FT                   /evidence="ECO:0000269|PubMed:18366185"
FT   MUTAGEN         163
FT                   /note="V->A: In GFPB; leads to enhanced fluorescence at 37
FT                   degrees Celsius. In GFPA; leads to even higher fluorescence
FT                   at 37 degrees Celsius than GFPA; whenassociated with G-175.
FT                   In alphaGFP/cycle 3 GFP; improves folding at 37 degrees
FT                   Celsius, reduces aggregation at high concentrations, and
FT                   increases the diffusibility of the protein inside cells;
FT                   when associated with S-99 and T-153. In R10-3; matures to
FT                   the red-emitting state with excitation and emission maxima
FT                   at 555 and 585 nm, respectively; when associated with L-46;
FT                   L-64; N-68; Q-162; V-167 and L-171. In ECFP; leads to cyan
FT                   fluorescence, folds faster and more efficiently at 37
FT                   degrees Celsius and has superior solubility and brightness;
FT                   when associated with L-64; T-65; W-66; I-146 and T-153. In
FT                   Cerulean; leads to improved quantum yield, a higher
FT                   extinction coefficient and is 2.5-fold brighter than ECFP;
FT                   when associated with L-64; T-65; W-66; A-72; A-145; I-146;
FT                   D-148 and T-153. In Venus; leads to yellow fluorescence,
FT                   improved maturation and reduced environmental sensitivity;
FT                   when associated with L-46; L-64; G-65; L-68; A-72; T-153;
FT                   G-175 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:12370172, ECO:0000269|PubMed:14990965,
FT                   ECO:0000269|PubMed:15065907, ECO:0000269|PubMed:18366185,
FT                   ECO:0000269|PubMed:8994830, ECO:0000269|PubMed:9370472,
FT                   ECO:0000269|PubMed:9630892, ECO:0000269|PubMed:9631088"
FT   MUTAGEN         167
FT                   /note="I->T: In P11; increases fluorescence at 475 nm
FT                   excitation and at warmer temperatures such as 37 degrees
FT                   Celsius. In Esmerald; leads to brighter fluorescence; when
FT                   associated with T-65; A-72; K-149 and T-153. In VisGreen;
FT                   leads to brighter fluorescence; when associated with L-64;
FT                   T-65; A-72 and K-149."
FT                   /evidence="ECO:0000269|PubMed:17658219,
FT                   ECO:0000269|PubMed:7809066, ECO:0000269|PubMed:9145105"
FT   MUTAGEN         167
FT                   /note="I->V: In P9; increases fluorescence at 475 nm
FT                   excitation. In R10-3; matures to the red-emitting state
FT                   with excitation and emission maxima at 555 and 585 nm,
FT                   respectively; when associated with L-46; L-64; N-68; Q-162;
FT                   A-163 and L-171."
FT                   /evidence="ECO:0000269|PubMed:18366185,
FT                   ECO:0000269|PubMed:7809066"
FT   MUTAGEN         171
FT                   /note="I->L: In R10-3; matures to the red-emitting state
FT                   with excitation and emission maxima at 555 and 585 nm,
FT                   respectively; when associated with L-46; L-64; N-68; Q-162;
FT                   A-163 and V-167."
FT                   /evidence="ECO:0000269|PubMed:18366185"
FT   MUTAGEN         171
FT                   /note="I->V: In EBFP1.2; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; A-
FT                   72; T-105; F-145; S-198 and V-206. In EBFP2.0; shifts the
FT                   excitation and emission spectra to shorter wavelengths and
FT                   increases quantum yields compared to BFP; when associated
FT                   with R-30; N-39; H-66; A-72; T-105; V-128; F-145; I-150; V-
FT                   155; S-198; V-206 and V-224."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   MUTAGEN         175
FT                   /note="S->G: In GFPA; leads to enhanced fluorescence at 37
FT                   degrees Celsius; when associated with A-163. In Venus;
FT                   leads to yellow fluorescence, improved maturation and
FT                   reduced environmental sensitivity; when associated with L-
FT                   46; L-64; G-65; L-68; A-72; T-153; A-163 and Y-203."
FT                   /evidence="ECO:0000269|PubMed:12370172,
FT                   ECO:0000269|PubMed:8994830"
FT   MUTAGEN         176
FT                   /note="V->A: In mut2.1; shifts fluorescence lifetime from
FT                   3.03 to 2.50 ns; when associated with H-145 and I-198."
FT                   /evidence="ECO:0000269|PubMed:16201762"
FT   MUTAGEN         193
FT                   /note="V->A: In mut1.5; shifts fluorescence lifetime from
FT                   3.03 to 2.72 ns; when associated with H-145."
FT                   /evidence="ECO:0000269|PubMed:16201762"
FT   MUTAGEN         198
FT                   /note="N->I: In mut2.1; shifts fluorescence lifetime from
FT                   3.03 to 2.50 ns; when associated with H-145 and A-176."
FT                   /evidence="ECO:0000269|PubMed:16201762"
FT   MUTAGEN         198
FT                   /note="N->S: In EBFP1.2; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; A-
FT                   72; T-105; F-145; V-171 and V-206. In EBFP2.0; shifts the
FT                   excitation and emission spectra to shorter wavelengths and
FT                   increases quantum yields compared to BFP; when associated
FT                   with R-30; N-39; H-66; A-72; T-105; V-128; F-145; I-150; V-
FT                   155; V-171; S-198 and V-224."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   MUTAGEN         202
FT                   /note="S->F: In H9; increases fluorescence at 395 nm
FT                   excitation; when associated with I-203."
FT                   /evidence="ECO:0000269|PubMed:7809066"
FT   MUTAGEN         203
FT                   /note="T->H,W,F: Results in significantly red-shifted
FT                   excitation and emission maxima."
FT                   /evidence="ECO:0000269|PubMed:8703075"
FT   MUTAGEN         203
FT                   /note="T->I: Suppresses the 475 nm excitation peak, leaving
FT                   only the shorter wavelength peak at 399 nm. In H9;
FT                   increases fluorescence at 395 nm excitation; when
FT                   associated with I-203. In Sapphire/H9-40; exhibits a huge
FT                   Stoke's shift, with an excitation peak at 399 nm and an
FT                   emission peak at 511 nm; when associated with A-72 and F-
FT                   145."
FT                   /evidence="ECO:0000269|PubMed:12769828,
FT                   ECO:0000269|PubMed:7796912, ECO:0000269|PubMed:7809066"
FT   MUTAGEN         203
FT                   /note="T->Y: Gives rise to yellow-emission variants. In
FT                   EYFP; leads to yellow fluorescence, folds faster and more
FT                   efficiently at 37 degrees Celsius and has superior
FT                   solubility and brightness; when associated with G-65; L-68
FT                   and A-72. In Citrinine; leads to excitation and emission
FT                   peaks of 516 and 529 nm, respectively; when associated with
FT                   L-68; M-69 and A-72. In YFP 10C; shifts the major emission
FT                   and exitation peak up to 20 nm; when associated with G-65;
FT                   L-68 and A-72. In Topaz; shifts the major emission and
FT                   exitation peak up to 20 nm; when associated with G-65; A-72
FT                   and R-79. In Venus; leads to yellow fluorescence, improved
FT                   maturation and reduced environmental sensitivity; when
FT                   associated with L-46; L-64; G-65; L-68; A-72; T-153; A-163
FT                   and G-175."
FT                   /evidence="ECO:0000269|PubMed:11299042,
FT                   ECO:0000269|PubMed:11387331, ECO:0000269|PubMed:12370172,
FT                   ECO:0000269|PubMed:9759496, ECO:0000269|PubMed:9782051"
FT   MUTAGEN         206
FT                   /note="A->K: Abolishes the tendency to dimerize and leads
FT                   to monomeric fluorescent proteins."
FT                   /evidence="ECO:0000269|PubMed:16739159"
FT   MUTAGEN         206
FT                   /note="A->V: In EBFP1.2; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; A-
FT                   72; T-105; F-145; V-171 and S-198. In EBFP2.0; shifts the
FT                   excitation and emission spectra to shorter wavelengths and
FT                   increases quantum yields compared to BFP; when associated
FT                   with R-30; N-39; H-66; A-72; T-105; V-128; F-145; I-150; V-
FT                   155; V-171; S-198 and V-206."
FT   MUTAGEN         222
FT                   /note="E->G: Suppresses the 399 nm excitation peak, leaving
FT                   only the longer wavelength peak at 475 nm."
FT                   /evidence="ECO:0000269|PubMed:7796912"
FT   MUTAGEN         224
FT                   /note="V->R: In Azurite; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with H-66; R-80; F-145 and
FT                   I-150. In EBFP2.0; shifts the excitation and emission
FT                   spectra to shorter wavelengths and increases quantum yields
FT                   compared to BFP; when associated with R-30; N-39; H-66; A-
FT                   72; T-105; V-128; F-145; I-150; V-155; V-171; S-198 and V-
FT                   206."
FT                   /evidence="ECO:0000269|PubMed:22891786"
FT   CONFLICT        2
FT                   /note="S -> G (in Ref. 3; CAA65278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        25
FT                   /note="H -> Q (in Ref. 3; CAA65278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80
FT                   /note="Q -> R (in Ref. 3; CAA65278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        157
FT                   /note="Q -> P (in Ref. 2; AAA58246)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        172
FT                   /note="E -> K (in Ref. 2; AAA58246)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..6
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          8..10
FT                   /evidence="ECO:0000244|PDB:3DQA"
FT   STRAND          12..22
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          25..36
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   HELIX           37..39
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          41..48
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          50..52
FT                   /evidence="ECO:0000244|PDB:5LEM"
FT   HELIX           57..60
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   HELIX           61..64
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   TURN            65..67
FT                   /evidence="ECO:0000244|PDB:1QYO"
FT   HELIX           69..71
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   HELIX           73..75
FT                   /evidence="ECO:0000244|PDB:3EVV"
FT   HELIX           76..81
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   HELIX           83..86
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   TURN            87..90
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          92..100
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          101..103
FT                   /evidence="ECO:0000244|PDB:6MWQ"
FT   STRAND          105..115
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          118..129
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          132..134
FT                   /evidence="ECO:0000244|PDB:1EMK"
FT   TURN            135..139
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          143..145
FT                   /evidence="ECO:0000244|PDB:3OSQ"
FT   STRAND          146..148
FT                   /evidence="ECO:0000244|PDB:4IK8"
FT   STRAND          149..155
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   HELIX           156..158
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          160..171
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   TURN            172..174
FT                   /evidence="ECO:0000244|PDB:4OGS"
FT   STRAND          176..187
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          189..191
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   STRAND          198..208
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   HELIX           209..213
FT                   /evidence="ECO:0000244|PDB:4IK8"
FT   STRAND          215..228
FT                   /evidence="ECO:0000244|PDB:6JGJ"
FT   HELIX           233..236
FT                   /evidence="ECO:0000244|PDB:4GF6"
SQ   SEQUENCE   238 AA;  26886 MW;  EA5A6F21FBFB6E05 CRC64;
     MSKGEELFTG VVPILVELDG DVNGHKFSVS GEGEGDATYG KLTLKFICTT GKLPVPWPTL
     VTTFSYGVQC FSRYPDHMKQ HDFFKSAMPE GYVQERTIFF KDDGNYKTRA EVKFEGDTLV
     NRIELKGIDF KEDGNILGHK LEYNYNSHNV YIMADKQKNG IKVNFKIRHN IEDGSVQLAD
     HYQQNTPIGD GPVLLPDNHY LSTQSALSKD PNEKRDHMVL LEFVTAAGIT HGMDELYK
//
